In patients receiving percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), post-conditioning therapy reduces infarct size and edema by one-third compared ...

A company developing a drug to address the growing need for safe ways to condition patients receiving cell and gene therapies is partnering with a firm developing single letter-level gene editing to ...

ORLANDO -- Myeloablative conditioning (MAC) led to a long-term survival benefit versus reduced-intensity conditioning (RIC) for patients with acute myeloid leukemia (AML) treated with hematopoietic ...

TBI has traditionally been an integral part of pre-transplantation conditioning. However, it is associated with substantial toxicity and undesirable long-term side effects. 2 On the basis of these ...

Quantitative analysis of leucocyte subsets by multiplex PCR using short tandem repeat (STR) markers and fluorescence detection system has been a useful tool for the assessment of chimeric states even ...

As a young pediatric oncologist, Kevin Heller was struck by the power of bone marrow transplants. While working at Memorial Sloan Kettering Cancer Center in the early 2000s, he saw how hematopoietic ...

REDWOOD CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, and Graphite Bio, Inc., a ...